Navigation Links
Cancer Game Changers: Genomics, Smarter Medicine, Care Coordination Comprise Medco's Advanced Oncology Solutions™
Date:7/19/2011

FRANKLIN LAKES, N.J., July 19, 2011 /PRNewswire/ -- Oncology treatments are not what they were a decade ago.  Drugs that target specific molecular pathways in a cancer cell are being added to or replacing once standard therapies, requiring a new model of patient care.  Medco Health Solutions, Inc. (NYSE: MHS) today announced new offerings within its Advanced Oncology Solutions™, that include treatment pathways decision support with embedded pharmacogenomic testing and nutrition recommendations for cancer patients.

(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)

Treatment Pathway Connections is the newest component in Medco's Advanced Oncology Solution's platform, which coordinates care among physicians, pharmacists, case managers and payers, and informs them of evidence-based protocols before and during treatment.  eviti®, a web-based oncology decision-support program developed by ITA Partners, Inc.®, will power the treatment plan decision-support function of the platform.

"Through eviti, our treatment pathway program is able to align quality care with reimbursement, reduce complexity, provide transparency and improve workflows for physicians and payers," said Jeff Ulanet, vice president oncology.  "Our goal is to reduce the gaps in care that negatively impact patient outcomes and can lead to unnecessary treatment costs."

Medco is the first PBM to offer this independent, comprehensive oncology decision support approach that contains more than 1,000 evidence based treatment regimens for more than 120 cancer types, displaying efficacy, costs, toxicity and compliance with the patient's plan language – all at the moment of prescribing.  ITA Partners, which employs a team of oncologists, oncology nurses, insurance professionals, actuaries, software designers and engineers has specialized in oncology de
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... , May 19, 2013  The non-surgical ... low temperature radiofrequency (RF) energy is effective in ... or reduces the need for medication 10 years ... presented today at the Digestive Disease Week (DDW) ... Florida . "The sustained ...
(Date:5/18/2013)... The Open Paradigm Project, in collaboration ... Psychiatry , and leading organizations in the movement ... media campaign showcasing video testimonials by individuals negatively ... on pathology and illness rather than wellness and ... Association,s (APA) rollout of its latest revision of ...
(Date:5/17/2013)... , May 17, 2013 The power of ... important ways in which mankind depends on the plant ... Garden,s multifaceted exhibition Wild Medicine: Healing ... on view from May 18 through September 8, ... The featured exhibition,s many attractions include a re-creation ...
Breaking Medicine Technology:Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2
... FOLD ) today announced that John F. Crowley ... Chairman in order to devote more time to interests related ... role as Executive Chairman, Mr. Crowley will continue to perform ... will advise the current Amicus management team on corporate strategy ...
... The board of directors of Eli Lilly and Company (NYSE: ... second quarter of 2011 of $0.49 a share on outstanding ... 10, 2011 to shareholders of record at the close of ... innovation-driven corporation, is developing a growing portfolio of pharmaceutical products ...
Cached Medicine Technology:Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman 2
(Date:5/20/2013)... (PRWEB) May 20, 2013 The ... Confectionery, Snacks, Breakfast Cereals, Baking Mixes & Flour, ... Conventional) & Geography — Global Trends & Forecasts ... product market with analysis and forecasting of the ... also identifies the driving and restraining factors for ...
(Date:5/20/2013)... 2013 B. E. Smith, the ... healthcare providers, has been retained to lead a ... Oswego Hospital in Oswego, N.Y. The top executive ... Smith has recently placed more than 900 healthcare ... a 164-bed, Joint Commission-accredited, acute care facility offering ...
(Date:5/20/2013)... Irritable Bowel Syndrome, or IBS, is commonly characterized ... habits, and is a difficult condition in which the ... of the colon may overreact to food, stress, exercise ... to an infection or a stressful life event. The ... a protein composite found in foods processed from wheat ...
(Date:5/20/2013)... 2013 The main objective for the present ... into a single comprehensive report. The objective was to ... this industry. Thus, it is timely to examine the ... an urgent need in the life science industry for technologies ... in a high-throughput, multiplex and low-cost way. Proteomic technologies ...
(Date:5/20/2013)... May 20, 2013 Pain Free ... relief products is excited to release a line ... arthritis pain relief. These magnetic health bracelets for ... with gemstones. Customers often report pain relief in ... demonstration at shows. , "Having made magnetic bracelets ...
Breaking Medicine News(10 mins):Health News:Gluten-Free Products Market to Reach $6,206.2 Million by 2018 at a CAGR of 10.2% - New Report by MarketsandMarkets 2Health News:Gluten-Free Products Market to Reach $6,206.2 Million by 2018 at a CAGR of 10.2% - New Report by MarketsandMarkets 3Health News:Oswego Hospital Retains B. E. Smith to Recruit New COO 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Offers improved hCG Diets With More Beneficial Nutritional Content, Possibly Offering Relief for Painful Symptoms of IBS 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Offers improved hCG Diets With More Beneficial Nutritional Content, Possibly Offering Relief for Painful Symptoms of IBS 3Health News:Proteomics Market - Mass Spectrometry & Biochips 2017 Forecast & Analysis in New Research Report at ReportsnReports.com 2Health News:Proteomics Market - Mass Spectrometry & Biochips 2017 Forecast & Analysis in New Research Report at ReportsnReports.com 3Health News:Handmade Magnetic Bracelets with Gemstones Announced by Pain Free Living 2
... , OAKBROOK TERRACE, Ill., Sept. 21 ... 2009 recipients of the annual John M. Eisenberg Patient Safety and Quality ... feature a new international category. , , ... INDIVIDUAL ACHIEVEMENT , Gary S. ...
... , Awardees will work with industry ... , WASHINGTON, Sept. 21 The U.S. Food ... stimulate the development and availability of medical devices for children. ... , , A panel of six experts with ...
... , Research features from Mayo Clinic , ... the fall issue of Discovery,s Edge, Mayo Clinic,s research magazine. ... wish. Reprinting is allowed with proper attribution. Please include the following subscription ... Discovery,s Edge for subscription information. , ...
... , , MONTREAL, ... integrated absence & disability management, today announced the release ... to comply with complex and overlapping FMLA (Family and ... regulations. Presagia,s ADA Toolkit will supplement Presagia,s Leave ...
... Dalton ... adding Formulation Development to its list of integrated capabilities. , ... Toronto, Ontario (PRWEB) September 21, 2009 -- ... by adding Formulation Development to its list of integrated capabilities. , , ...
... , , ... of emergency department (ED) clinical documentation tools, today announced it ... recent recommendations of the Centers for Disease Control and Prevention ... the T-System Web site ( www.tsystem.com/h1n1flu ), now ...
Cached Medicine News:Health News:2009 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 2Health News:2009 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 3Health News:2009 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 4Health News:FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 2Health News:FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 3Health News:Discovery's Edge Fall Issue -- http://discoverysedge.mayo.edu/ 2Health News:Discovery's Edge Fall Issue -- http://discoverysedge.mayo.edu/ 3Health News:Presagia Solution Helps Employers Navigate Overlapping ADA and FMLA Regulations 2Health News:Presagia Solution Helps Employers Navigate Overlapping ADA and FMLA Regulations 3Health News:Dalton Pharma Services Adds Formulation Development Services 2Health News:T-System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines, Adds Discharge Instructions 2Health News:T-System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines, Adds Discharge Instructions 3
Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts...
Lumbar Allograft with Osteoactive advantage. Promotes bone formation and faster incorporation. Derived from the proven technology behind Grafton DBM. Maintains structural integrity and strength....
Seletz-Gelpi Laminectomy Retractor, self-retaining with arms bent at right angles....
Scoville-Haverfield Hemilaminectomy Retractor...
Medicine Products: